Mfn2 modulates the UPR and mitochondrial function via repression of PERK

Authors

  • Juan Pablo Muñoz,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Saška Ivanova,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Jana Sánchez-Wandelmer,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Paula Martínez-Cristóbal,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Eduard Noguera,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Ana Sancho,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Angels Díaz-Ramos,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • María Isabel Hernández-Alvarez,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • David Sebastián,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Caroline Mauvezin,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Manuel Palacín,

    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author
  • Antonio Zorzano

    Corresponding author
    1. Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain
    2. Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
    3. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain
    Search for more papers by this author

Errata

This article corrects:

  1. Mfn2 modulates the UPR and mitochondrial function via repression of PERK Volume 32, Issue 17, 2348–2361, Article first published online: 6 August 2013

No abstract is available for this article.

Ancillary